This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tiumbio Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Minhee Lee: Innovator in Pharmaceutical Chemistry
Introduction
Minhee Lee is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on furopyrimidine compounds. His research focuses on developing compounds with enhanced physicochemical properties for pharmaceutical applications.
Latest Patents
Minhee Lee holds 1 patent for his invention titled "Salt and crystalline form of furopyrimidine compound and pharmaceutical use thereof." This patent describes salts and crystalline forms of a specific compound, which exhibit excellent physicochemical properties, including hygroscopicity, chemical stability, and low levels of related substances. These characteristics make the compounds suitable for use as active ingredients in pharmaceutical compositions.
Career Highlights
Throughout his career, Minhee Lee has demonstrated a commitment to advancing pharmaceutical science. His work has led to the development of compounds that can potentially improve drug formulations and therapeutic outcomes. He is associated with Tiumbio Co., Ltd., where he continues to innovate in the field.
Collaborations
Minhee Lee has collaborated with several talented individuals, including Seon-Mi Kim and Hun-Taek Kim. These collaborations have contributed to the successful development of his patented compounds and further advancements in pharmaceutical research.
Conclusion
Minhee Lee's contributions to pharmaceutical chemistry highlight the importance of innovation in developing effective drug formulations. His work continues to pave the way for advancements in the field, showcasing the potential of furopyrimidine compounds in pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile